MATINAS BIOPHARMA HOLDINGS, INC. Other Significant Noncash Transaction, Value of Consideration Given
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Other Significant Noncash Transaction, Value of Consideration Given of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1 · last filed 2018-03-16
- MATINAS BIOPHARMA HOLDINGS, INC. other significant noncash transaction, value of consideration given for the quarter ending 2016-12-31 was $0.00, a 100.00% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. other significant noncash transaction, value of consideration given for the quarter ending 2016-09-30 was $0.00.
- MATINAS BIOPHARMA HOLDINGS, INC. other significant noncash transaction, value of consideration given for the quarter ending 2016-06-30 was $0.00.
- MATINAS BIOPHARMA HOLDINGS, INC. other significant noncash transaction, value of consideration given for the quarter ending 2016-03-31 was $0.00.
- MATINAS BIOPHARMA HOLDINGS, INC. other significant noncash transaction, value of consideration given for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- MATINAS BIOPHARMA HOLDINGS, INC. other significant noncash transaction, value of consideration given for fiscal 2015 was $2.12M.
- MATINAS BIOPHARMA HOLDINGS, INC. other significant noncash transaction, value of consideration given for fiscal 2014 was $0.00.
| Period end | Other Significant Noncash Transaction, Value of Consideration Given 3 month | Other Significant Noncash Transaction, Value of Consideration Given 3 month as first filed | Other Significant Noncash Transaction, Value of Consideration Given 6 month | Other Significant Noncash Transaction, Value of Consideration Given 6 month as first filed | Other Significant Noncash Transaction, Value of Consideration Given 9 month | Other Significant Noncash Transaction, Value of Consideration Given 9 month as first filed | Other Significant Noncash Transaction, Value of Consideration Given 12 month |
|---|---|---|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $0.00 derived: sum of 2 quarters · filed 2017-03-31 | $0.00 derived: sum of 3 quarters · filed 2017-03-31 | $0.00 10-K · filed 2017-03-31 | |||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2016-11-14 | $0.00 10-Q · filed 2016-11-14 | $4.24M derived: sum of 4 quarters · filed 2018-03-16 | |||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $0.00 10-Q · filed 2016-08-15 | $4.24M derived: sum of 3 quarters · filed 2018-03-16 | $4.24M derived: sum of 4 quarters · filed 2018-03-16 | |||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-13 | $4.24M derived: sum of 2 quarters · filed 2018-03-16 | $4.24M derived: sum of 3 quarters · filed 2018-03-16 | $4.24M derived: sum of 4 quarters · filed 2018-03-16 | |||
| 2015-12-31 | $4.24M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $4.24M derived: sum of 2 quarters · filed 2018-03-16 | $4.24M derived: sum of 3 quarters · filed 2018-03-16 | $2.12M 10-K · filed 2018-03-16 | |||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2016-11-14 | -$2.12M 10-Q · filed 2016-11-14 | $2.12M 10-Q · filed 2015-11-10 | -$2.12M derived: sum of 4 quarters · filed 2016-11-14 | ||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$2.12M 10-Q · filed 2016-08-15 | $2.12M 10-Q · filed 2015-08-13 | -$2.12M derived: sum of 3 quarters · filed 2016-08-15 | -$2.12M derived: sum of 4 quarters · filed 2016-08-15 | ||
| 2015-03-31 | -$2.12M 10-Q · filed 2016-05-13 | $2.12M 10-Q · filed 2015-05-15 | -$2.12M derived: sum of 2 quarters · filed 2016-05-13 | -$2.12M derived: sum of 3 quarters · filed 2016-05-13 | -$2.12M derived: sum of 4 quarters · filed 2016-05-13 | ||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $0.00 derived: sum of 2 quarters · filed 2016-03-30 | $0.00 derived: sum of 3 quarters · filed 2016-03-30 | $0.00 10-K · filed 2016-03-30 | |||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $0.00 derived: sum of 2 quarters · filed 2015-11-10 | $0.00 10-Q · filed 2015-11-10 | ||||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $0.00 10-Q · filed 2015-08-13 | |||||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |